2017 annual financial data
BridgeBio Pharma 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -43,858,000 USD and net income was -30,565,000 USD.
Operating cash flow was -40,488,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -43,858,000 USD
- Net income
- -30,565,000 USD
- Operating cash flow
- -40,488,000 USD